Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![GmtEight08 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1894642654811754499.png) GMT EIGHT [@GmtEight08](/creator/twitter/GmtEight08) on x 3069 followers
Created: 2025-07-21 08:00:02 UTC

AbbVie earned a Buy rating from Morgan Stanley with a $XXX price target, citing low volatility and strong Q1 results: $XXXX EPS (+6.5% YoY) and $13.343B revenue (+9.8% operational growth).


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947204909939691860/c:line.svg)

**Related Topics**
[$13343b](/topic/$13343b)
[eps](/topic/eps)
[$abbv](/topic/$abbv)
[stocks healthcare](/topic/stocks-healthcare)
[morgan stanley](/topic/morgan-stanley)
[stocks financial services](/topic/stocks-financial-services)

[Post Link](https://x.com/GmtEight08/status/1947204909939691860)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

GmtEight08 Avatar GMT EIGHT @GmtEight08 on x 3069 followers Created: 2025-07-21 08:00:02 UTC

AbbVie earned a Buy rating from Morgan Stanley with a $XXX price target, citing low volatility and strong Q1 results: $XXXX EPS (+6.5% YoY) and $13.343B revenue (+9.8% operational growth).

XX engagements

Engagements Line Chart

Related Topics $13343b eps $abbv stocks healthcare morgan stanley stocks financial services

Post Link

post/tweet::1947204909939691860
/post/tweet::1947204909939691860